allergan

Welcome to the 'allergan' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'allergan'.

Original Technorati articles tagged “allergan”

• in Business
  Allergan Victorious in Patent Infringement Lawsuit
  District Court rules ALPHAGAN® P patents enforceable and infringed by Apotex and Exela.
  by ipwatchdog / on Oct 25, 2009

Latest blogosphere posts tagged “allergan”

• The Impact of Aging on Male Sexuality.

  
  Medical, Drugs, Pharmaceuticals And Diseases Information — Authority: 122
  http://www.rudramani.com The Impact of Aging on Male Sexuality.There has been a number of advances in understanding the ways in which aging damages a man’s ability to perform sexually Technology designed elderly couples, and, particularly, on solutions to the problems aging men face Greater interest is ...
  3 days ago

• anti wrinkle cream, which incorporates J&J’s tretinoin acne and anti wrinkle ointment

  
  Medical, Drugs, Pharmaceuticals And Diseases Information — Authority: 122
  http://www.rudramani.com Aging baby boomers and increasing segmentation are driving a shift investment in R&D Johnson & Johnson’s (J&J) Re a anti wrinkle cream, which incorporates J&J’s tretinoin acne and anti wrinkle ointment, was perhaps the most Accelerated Aging of Immune ...
  5 days ago

• Study: Lap band surgery effective for morbidly obese children

  
  Science Blog - Science news straight from the source — Authority: 617
  Washington, DC -- A surgeon now at Childrens National Medical Center and his colleagues from New York University have found laparoscopic adjustable gastric banding (Lap band) to improve the health
  6 days ago

• Earnings highlights: Aetna, Allergan, E*Trade, Goodyear, RadioShack, SAP, Visa ...

  
  BloggingStocks — Authority: 665
  Filed under: Earnings reports , Allergan (AGN) , Aetna Inc (AET) , TD AmeriTrade Holding (AMTD) , RadioShack Corp (RSH) , Goodyear Tire and Rubber (GT) , E*TRADE (ETFC) , Visa Inc. (V) Here are some highlights from last weeks earnings coverage from BloggingStocks: Aetna Inc. (NYSE: AET ) reported ...
  1 week ago

• Swine flu vaccine sales lift Glaxo, AstraZeneca and Sanofi

  
  DailyFinance — Authority: 790
  Filed under: Company News , Earnings While the swine flu pandemic remains a downer for public health officials worldwide, the H1N1 virus proved to be an upper for several pharmaceutical companies third-quarter earnings. GlaxoSmithKline ( GSK ), AstraZeneca ( AZN ) and Sanofi-Aventis ( SNY ), which make vaccines ...
  1 week ago

• Irvine-based Allergan Inc. Releases Third-Quarter Reports

  
  DataGrant Venture Capital News — Authority: 128
  On Thursday, Irvine-based Allergan Inc., which is into making Botox, medical cosmetic products and other drugs, announced its Q3 profits which equaled Wall Street’s estimates. This gave a very positive outlook for the current quarter. Sales of the third quarter were reported at $1.13 billion, which is 4% more from ...
  1 week ago

• Restasis HCP print ad

  
  AdPharm Blog — Authority: 141
  Click on the images to see the full-sized ads and get all the info on AdPharm. To see all of this brand’s ads on AdPharm, click here
  1 week ago

• Brooke Shields Has Hypotrichosis [Absurd]

  
  Consumerist — Authority: 777
  Oh no! Brooke Shields used to have stringy, stick-figure eyelashes! I figured this out after watching Consumer Reports video dissection of a new commercial for Latisse , the glaucoma medication that has been rebranded as an expensive, temporary eyelash enhancer with side effects . Since its still a drug and not an ...
  1 week ago

• Allergan Victory in ALPHAGAN® P Patent Infringemet Suit

  
  IPWatchdog.com | Patents & Patent Law — Authority: 579
  The United States District Court for the District of Delaware handed Allergan, Inc. (NYSE:AGN) a victory last week in its patent infringement lawsuit brought against Exela PharmSci, Inc., Exela PharmSci Pvt., Ltd., Apotex, Inc. and Apotex Corp. The defendants had been seeking permission to market generic versions of ...
  2 weeks ago

• Consumer advocate blasts Latisse eyelash drug ads

  
  The Orange County Register - Tustin — Authority: 825
  Direct-to-consumer ads downplay side effects, Consumer Reports blog says.
  2 weeks ago

• (ACL) Alcon Continues to Grow Pipeline

  
  Stock Blog Hub — Authority: 506
  Alcon, Inc. ( ACL ) recently entered into an in-licensing agreement with Potentia Pharmaceuticals, a privately-held biotechnology company that focuses on the development of medicines for the treatment of age-related macular degeneration (AMD). Alcon gained the right to develop Potentia’s leading drug candidate, ...
  2 weeks ago

• Combigan for patients who need adjunctive IOP lowering…

  
  AdPharm Blog — Authority: 141
  Click on image to view ad details and full-size version on AdPharm.
  2 weeks ago

• Allergan Wins Patent Suit

  
  socalTECH.com - Southern California High Tech News — Authority: 561
  Irvine-based Allergan is reporting this morning that it has won a patent infringement case against Exela PharmSci, Inc., Exela PharmSci Pvt., Ltd., Apotex, Inc. and Apotex Corp. in the US District Court for the District of Delaware. Allergan said the defendants were looking to make generic versions of its ALPHAGAN P ...
  2 weeks ago

• FDA Warns About Eyelash Thickener Claims

  
  Find Me A Cure — Authority: 134
  The U.S. FDA has warned Allergan Inc. that the Web site for its eyelash thickener Latisse is misleading. The site downplays or fails to mention risks associated with the product. ….. ….. ……. The Latisse site either doesn’t mention potential side effects including bacterial eye infections, allergic ...
  3 weeks ago

• Allergan Sues FDA for Free Speech Violation

  
  Cosmetic Surgery Today — Authority: 127
  Allergan, the makers of BOTOX Cosmetic and other skin rejuvenation products, has filed a complaint in federal court in Washington against the U.S. Food and Drug Administration for violation of First Amendment rights. A recent report in the New York Times indicates that the Food and Drug Administration has ...
  3 weeks ago

• (SLTM) Solta Medical’s Laser Device Approved by The FDA

  
  Stock Blog Hub — Authority: 506
  After the closing bell on Wednesday, Solta Medical Inc. (SLTM) announced that the U.S. Food and Drug Administration (FDA) approved its device to clear pigmentation and other superficial skin conditions. The device, called the Fraxel re:store Dual Laser System, can be used both on the face and large body areas to ...
  3 weeks ago

• Grow some lush lashes now without the prescription

  
  The Informed Makeup Maven — Authority: 132
  Ever since Allergans Latisse received FDA approval as an eye lash growth stimulator weve seen a wealth of lash enhancing potions hit the market some hormone based others wholly natural, plant and organic based ( Lash Trio and Lipocils). As Im not likely to ever smear hormone or pharmaceutical products anywhere ...
  4 weeks ago

• Red Tape Alert: New FDA Rule Puts Allergan In A Double Bind

  
  Better Health — Authority: 602
  I was reading my daily MedPage Today news, when I came across this amusing example of regulatory unintended consequences. As we all know, pharmaceutical companies are not allowed to promote off-label uses of their medications - doing so is punishable with billions of dollars in fines (just ask Pfizer ). But a new ...
  5 weeks ago

• Allergan, makers of Botox and Latisse sue the FDA for right to market off-label

  
  soulful sepulcher — Authority: 127
  Via Furious Seasons blog:The pharmaceutical company, Allergan, the company that makes Botox and the eye lash growth product, Latisse has taken the federal government to court for the right to sell off-label use Botox.Allergan said the current restrictive policy of the Justice Department and FDA violates the companys ...
  5 weeks ago

• Allergan Sues FDA over Wrinkle in Off Label Use of Botox

  
  Bio Job Blog — Authority: 470
  Allergan, the maker of Botox and Latisse sued the US Food and Drug Administration (FDA) in federal court yesterday because it believes that regulations banning off label promotion of prescription drugs violates the company’s right to freedom of speech and impedes its ability to provide physicians with ...
  5 weeks ago

Comments about allergan